Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by VU University Medical Center
Sponsor:
Collaborators:
Dutch Cancer Society
Novartis
Information provided by (Responsible Party):
Hans J. van der Vliet, MD, PhD, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01462214
First received: October 10, 2011
Last updated: April 29, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):